Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Christelle Bouchart"'
Autor:
Guus Grimbergen, Hidde Eijkelenkamp, Louk M.W. Snoeren, Rana Bahij, Uffe Bernchou, Erik van der Bijl, Hanne D. Heerkens, Shawn Binda, Sylvia S.W. Ng, Christelle Bouchart, Zelda Paquier, Kerryn Brown, Richard Khor, Robert Chuter, Linnéa Freear, Alex Dunlop, Robert Adam Mitchell, Beth A. Erickson, William A. Hall, Paola Godoy Scripes, Neelam Tyagi, Jeremiah de Leon, Charles Tran, Seungjong Oh, Paul Renz, Andrea Shessel, Edward Taylor, Martijn P.W. Intven, Gert J. Meijer
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 47, Iss , Pp 100797- (2024)
Background and purpose: Treatment planning for MR-guided stereotactic body radiotherapy (SBRT) for pancreatic tumors can be challenging, leading to a wide variation of protocols and practices. This study aimed to harmonize treatment planning by devel
Externí odkaz:
https://doaj.org/article/071a76da20144668a7eb39a5afdc91e1
Autor:
Christelle Bouchart, Julie Navez, Ivan Borbath, Karen Geboes, Timon Vandamme, Jean Closset, Luigi Moretti, Pieter Demetter, Marianne Paesmans, Jean-Luc Van Laethem
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background For patients with pancreatic ductal adenocarcinoma (PDAC), surgical resection remains the only potentially curative treatment. Surgery is generally followed by postoperative chemotherapy associated with improved survival, yet neoa
Externí odkaz:
https://doaj.org/article/c0ba162ecbac4627a626efe80bec5fcd
Autor:
Rita Saúde-Conde, Benjelloun El Ghali, Julie Navez, Christelle Bouchart, Jean-Luc Van Laethem
Publikováno v:
Cancers, Vol 16, Iss 13, p 2423 (2024)
Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge in oncology due to its advanced stage upon diagnosis and limited treatment options. Surgical resection, the primary curative approach, often results in poor long-term survival rate
Externí odkaz:
https://doaj.org/article/d4918cd4bf4346f7b8b00abf85546c44
Autor:
Rita Saúde-Conde, Ayça Arçay Öztürk, Kosta Stosic, Oier Azurmendi Senar, Julie Navez, Christelle Bouchart, Tatjana Arsenijevic, Patrick Flamen, Jean-Luc Van Laethem
Publikováno v:
Biomedicines, Vol 12, Iss 3, p 591 (2024)
Pancreatic ductal adenocarcinoma (PDAC) represents a formidable challenge due to its aggressive nature and poor prognosis. The tumor microenvironment (TME) in PDAC, characterized by intense stromal desmoplastic reactions and a dominant presence of ca
Externí odkaz:
https://doaj.org/article/b172f1663aed47dfae3a67509ed276b1
Autor:
Kosta Stosic, Oier Azurmendi Senar, Jawad Tarfouss, Christelle Bouchart, Julie Navez, Jean-Luc Van Laethem, Tatjana Arsenijevic
Publikováno v:
Cells, Vol 13, Iss 1, p 3 (2023)
Pancreatic ductal adenocarcinoma is one of the most lethal malignant diseases, with a mortality rate being close to incidence. Due to its heterogeneity and plasticity, as well as the lack of distinct symptoms in the early phases, it is very often dia
Externí odkaz:
https://doaj.org/article/223f6384ceb640cfa87ac4c0be58a84a
Autor:
Chrysanthi Iliadi, Laurine Verset, Christelle Bouchart, Philippe Martinive, Dirk Van Gestel, Mohammad Krayem
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Radiotherapy is part of the standard of care treatment for a great majority of cancer patients. As a result of radiation, both tumor cells and the environment around them are affected directly by radiation, which mainly primes but also might limit th
Externí odkaz:
https://doaj.org/article/11c12be77cfc435b929ca6c447021cbd
Autor:
Sofian Benkhaled, Cedric Peters, Nicolas Jullian, Tatjana Arsenijevic, Julie Navez, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Publikováno v:
Cancers, Vol 15, Iss 3, p 768 (2023)
Pancreatic ductal adenocarcinoma cancer (PDAC) is a highly diverse disease with low tumor immunogenicity. PDAC is also one of the deadliest solid tumor and will remain a common cause of cancer death in the future. Treatment options are limited, and t
Externí odkaz:
https://doaj.org/article/40a8921a2e864f3f9270d6fb4b63be8a
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1069-1078 (2020)
Abstract Aims Glioblastoma (GBM) is the most common and lethal malignant brain tumor in adults. Glioma stem cells (GSCs) are implicated in this poor prognosis and in radio(chemo‐)resistance. We have previously demonstrated that among potentially hi
Externí odkaz:
https://doaj.org/article/53c9862235d347629530ae72d4961d74
Autor:
Christelle Bouchart, Jean-Luc Engelholm, Jean Closset, Julie Navez, Patrizia Loi, Yeter Gökburun, Thierry De Grez, Laura Mans, Alain Hendlisz, Maria Antonietta Bali, Pierre Eisendrath, Dirk Van Gestel, Matthieu Hein, Luigi Moretti, Jean-Luc Van Laethem
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Our aim was to evaluate the feasibility and safety of isotoxic high-dose (iHD) stereotactic body radiation therapy (SBRT) in a total neoadjuvant sequence for the treatment of localized pancreatic adenocarcinoma. Materials and methods: Bio
Externí odkaz:
https://doaj.org/article/a6a324b1341e438abd8a06cb0290e051
Autor:
Martin Manderlier, Julie Navez, Matthieu Hein, Jean-Luc Engelholm, Jean Closset, Maria Antonietta Bali, Dirk Van Gestel, Luigi Moretti, Jean-Luc Van Laethem, Christelle Bouchart
Publikováno v:
Cancers, Vol 14, Iss 23, p 5730 (2022)
Given the lack of direct comparative evidence, we aimed to compare the oncological outcomes of localized pancreatic ductal adenocarcinoma (PDAC) treated in the same tertiary cancer center with isotoxic high-dose stereotactic body radiotherapy (iHD-SB
Externí odkaz:
https://doaj.org/article/8fb29b34039a4556910eaa6a4eea2b07